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Genome-wide association studies (GWAS) have been successfully used to call for variants associated with diseases including type
2 diabetes mellitus (T2DM). However, some variants are not included in the GWAS to avoid penalty in multiple hypothetic testing.
Thus, candidate gene approach is still useful even at GWAS era. This study attempted to assess whether genetic variations in the
renin-angiotensin system (RAS) and their gene interactions are associated with T2DM risk. We genotyped 290 T2DM patients and
267 controls using three genes of the RAS, namely, angiotensin converting enzyme (ACE), angiotensinogen (AGT), and angiotensin
II type 1 receptor (AGTR1). There were significant differences in allele frequencies between cases and controls for AGT variants
(𝑃 = 0.05) but not for ACE and AGTR1. Haplotype TCG of the AGT was associated with increased risk of T2DM (OR 1.92, 95%
CI 1.15–3.20, permuted 𝑃 = 0.012); however, no evidence of significant gene-gene interactions was seen. Nonetheless, our analysis
revealed that the associations of theAGT variants with T2DMwere independently associated.Thus, this study suggests that genetic
variants of the RAS can modestly influence the T2DM risk.
1. Introduction
Type 2 diabetes mellitus (T2DM) is a major public health
concern and affected patients stand a higher risk of suffering
the injurious effects of hyperglycemia such as coronary artery
disease, peripheral arterial disease, and ultimately stroke [1].
Prolonged hyperglycemia could lead to the development of
microvascular complications such as diabetic nephropathy,
neuropathy, and retinopathy [2]. The number of individuals
with diabetes is on the rise and the figure is expected to reach
552million by 2030 owing tomany factors such as population
growth, aging, urbanisation, obesity, and physical inactivity
[3]. Although environmental factors are reasons often consid-
ered, it is important to keep in mind that environmental fac-
tors, by themselves, represent only a fraction of cases. Individ-
uals with family history of T2DM are at higher risk of devel-
oping the disease as shown in familial studies [4] suggesting
strong genetic contribution.
Now that the genome-wide association studies (GWAS)
are feasible, allowing genetic data to be collected at unprece-
dented rates, many disease-associated alleles have been iden-
tified through GWAS and applied to T2DM [5]. Notwith-
standing that, one cannot deny that the candidate gene
approach has been a pioneer and at a forefront of genetic asso-
ciation studies. The so-called genome-wide significance level
(𝑃 < 5 × 108) has limited the common and rare variants cap-
turing and hence contribute to the missing heritability. Thus,
candidate gene approach is still valuable even at the GWAS
era. The roles of renin-angiotensin system (RAS) in insulin
signaling pathway and insulin resistance have been well doc-
umented [6]. The blockade of the system has been shown to
have beneficial effects in the prevention of T2DM [7]. These
findings strongly imply that the variations in RAS might be
associated with the onset of T2DM. Nevertheless, the under-
lying genetic mechanisms of the RAS and susceptibility to
T2DM remain poorly understood.
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In this study, we examined the association of genetic
variations of the RAS with susceptibility to T2DM in the
Malaysian Malays. While most of the reports are centered
on the Western populations, little is known about the data
from the Asians. Furthermore, theMalaysianMalays differ in
terms of population structure among other Asians including
the Chinese and Japanese [8]. However, whether or not the
genetic variations of the RAS contribute to the risk difference
of T2DMremains to be investigated and is a hypothesis of this
study. We also examined the gene-gene interactions within
the system in order to understand the gene-gene effect on the
occurrence of T2DM.
2. Methods
2.1. Study Participants. This study consisted of 557 Malay
participants, 290 of which are T2DM patients and 267 are
controls recruited from the University Malaya Medical Cen-
tre (UMMC). T2DM patients and controls were matched
by age with mean age of 57.4 and 57.0, respectively. T2DM
was diagnosed by qualified clinicians based on fasting blood
glucose (FBG) levels≥7.0mmol/L for two consecutive routine
screen readings and glycated haemoglobin (HbA1c) ≥6.5%
(≥48mmol/mol) with normoalbuminuria, and without a his-
tory of any renal complications. Controls were those coming
for routine health screening at clinics, with no evidence or
family history of T2DM. The study was approved by the
medical ethics committee of the UMMC and was performed
according to the Declaration of Helsinki. Written informed
consent was obtained from all study participants prior to
participation into the study.
2.2. Laboratory andClinical Data. Anthropometric data such
as height (cm), weight (kg), body mass index (BMI, kg/m2),
and waist circumference were determined as standard proto-
col. Measurement of blood pressure (mmHg) was according
to standard recommendation and clinical practice guidelines.
The biochemical tests for the determination of fasting blood
glucose (mmol/L), HbA1C (%, mmol/mol), serum urea
(mmol/L), serum creatinine (mmol/L), glomerular filtration
rate (GFR) (mL/min/1.72m2), serum triglyceride (mmol/L),
serum cholesterol (mmol/L), high density lipoprotein (HDL)
(mmol/L), and low density lipoprotein (LDL) (mmol/L) were
according to standard clinical laboratorymethods carried out
in an accredited laboratory at UMMC. Other clinical data
included were information on duration of diabetes, presence
of any complication, and history of other disorders.
2.3. Genotyping. Genomic DNA was extracted from periph-
eral blood leucocytes using the QIAamp DNA Blood Mini
Kit (Qiagen, Valencia, CA, USA) according tomanufacturer’s
protocols. Genotyping was carried out for the selected vari-
ants: angiotensin converting enzyme (ACE) rs4344, rs4359,
rs4363, rs4459609, rs1800764, and ACE Insertion/Deletion;
angiotensinogen (AGT) rs699, rs4762, and rs5051; and
angiotensin II type 1 receptor (AGTR1) rs388915. Amplifica-
tion and quantitative real-time RT-PCR analyses were carried
out by using Step One Real Time PCR system (Applied
Biosystems, USA). The total reaction volume for each well
was 10 𝜇L containing 5 𝜇L (2x) TaqMan Genotyping Master
Mix (Applied Biosystems, USA), 0.5 𝜇L customized assaymix
(20x) containing sense and antisense primers and TaqMan
probe (Applied Biosystems,USA) specific to each gene, 3.5 𝜇L
distilled water, and 1 𝜇L (10–20 ng) genomic DNA. Cycles
were 60∘C for 30 sec, a 10min 95∘C denaturing step, followed
by 40 cycles of 95∘C denaturation, incubated at 60∘C for
1min, and denatured at 95∘C for 15 sec for the final step.
2.4. Statistical Analysis. All statistical tests were performed
using SPSS version 18.0 (IBM Corp., Chicago, IL, USA),
otherwise mentioned. Data were presented as percentage
or mean ± standard deviation (S.D.). Categorical and con-
tinuous variables were compared between patients with
diabetes and patients without diabetes using Pearson’s 𝜒2 test,
independent 𝑡-test, andMann-Whitney𝑈 test as appropriate.
Hardy-Weinberg equilibrium (HWE) was checked for the
genotype distribution prior to genetic analysis using a good-
ness of fit 𝜒2 test. Deviation from HWE was called when the
𝑃 < 0.05. Odds ratios and 95% confidence interval (CI) for
the findings were computed using logistic regression. Mul-
tivariate analysis revealed that gender, waist circumference,
andwaist-to-hip ratio (WHR) are contributing factors associ-
ated with T2DM. Gender was collapsed intomen and women
in the subsequent analysis; thus, adjustment would render
unnecessary. Waist circumference was used in the multiple
logistic regression as suggested earlier [9]. Correction for
multiple testing was performed using Bonferroni’s method.
Linkage disequilibrium (LD) and haplotype analyses were
computed using Haploview 4.2 program. 𝑃 values for haplo-
type analysis were calculated based on 100,000 permutations.
The odds ratio for the haplotype association was calculated
using R program version 2.11.1. Parameter comparisons
among genotypes were tested using Analysis of Variance
(ANOVA) and Kruskal-Wallis as appropriate. Linear regres-
sion was used to assess the correlation between genetic
variants and clinical parameters for normally distributed
variables; otherwise, Spearman’s correlation test was adopted.
A two-sided 𝑃 value of <0.05 is considered to be statistically
significant. To investigate the influence of gene-gene inter-
action on T2DM, Generalized Multifactor Dimensionality
Reduction (GMDR) method was employed. All possible
interactions were tested using 10-fold cross validation with
exhaustive search, which considers all possible variable com-
binations.
3. Results
The demographic and clinical data of the participants are
shown in Table 1. Gender was matched between patients
and controls. Patients and controls were significantly dif-
fered in waist circumference, WHR, fasting blood glucose,
HbA1c, serum urea, serum creatinine, serum triglyceride,
serum cholesterol, high density lipoprotein, and low density
lipoprotein (𝑃 < 0.05). Knowing gender as a risk for
diabetes and Asian men are particularly at more risk for the
disease [10], we further described the comparison in male.
Significant differences were also observed in waist circumfer-
ence, WHR, fasting blood glucose, HbA1c, serum creatinine,
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Table 1: Demographic and clinical data of participants.
Characteristics 𝑛 (%) or mean ± SD 𝑃 value
Control (𝑛 = 267) DM (𝑛 = 290)
Gender 0.824a
Male 108 (40) 120 (41)
Female 159 (60) 170 (59)
Age 57.0 ± 6.9 57.4 ± 6.2 0.618
BMI (kg/m2) 26.9 ± 4.9 27.3 ± 4.6 0.317b
Waist circumference (cm) 86.3 ± 12.7 91.8 ± 11.9 <0.000b
Waist-to-hip ratio 0.87 ± 0.1 0.90 ± 0.1 <0.0001
Systolic blood pressure (mmHg) 131.7 ± 15.5 133.7 ± 15.8 0.058
Diastolic blood pressure (mmHg) 78.8 ± 10.3 77.8 ± 8.5 0.650
Fasting blood glucose (mmol/L) 5.3 ± 0.7 8.4 ± 3.1 <0.0001
HbA1c (%) (mmol/mol) 5.5 ± 0.5 (36 ± 6) 8.8 ± 1.9 (73 ± 21) <0.0001
Serum urea (mmol/L) 5.5 ± 7.8 5.3 ± 1.8 <0.0001
Serum creatinine (mmol/L) 76.9 ± 22.6 86.3 ± 25.3 <0.0001
Glomerular filtration rate (mL/min/1.7m2) 85.4 ± 25.1 77.4 ± 23.3 0.988b
Triglyceride (mmol/L) 1.8 ± 5.2 1.8 ± 0.9 <0.0001
Total cholesterol (mmol/L) 5.2 ± 3.8 4.8 ± 3.2 <0.0001
HDL cholesterol (mmol/L) 1.9 ± 8.2 1.6 ± 5.9 <0.0001
LDL cholesterol (mmol/L) 3.0 ± 0.9 2.6 ± 1.0 <0.0001
a
𝑃 values were obtained using Pearson’s 𝜒2 test, b𝑃 values were obtained using independent 𝑡-test, and other comparisons used Mann-Whitney𝑈 test.
Table 2: Demographic and clinical data of male participants.
Characteristics Mean ± SD 𝑃 value
Control (𝑛 = 108) DM (𝑛 = 120)
Age (years) 57.4 ± 6.8 58.13 ± 6.2 0.753a
BMI (kg/m2) 26.7 ± 4.1 27.2 ± 4.1 0.986a
Waist circumference (cm) 90.8 ± 11.1 95.3 ± 11.7 0.003a
Waist-to-hip ratio 0.90 ± 0.1 0.94 ± 0.1 <0.0001
Systolic pressure (mmHg) 131.30 ± 15.7 133.78 ± 14.9 0.112
Diastolic pressure (mmHg) 79.11 ± 10.3 78.22 ± 9.0 0.676
Fasting blood glucose (mmol/L) 5.29 ± 0.7 8.33 ± 2.8 <0.0001
HbA1c (%) (mmol/mol) 5.44 ± 0.5 (35.93 ± 5.6) 8.65 ± 2.0 (70.98 ± 21.7) <0.0001
Serum urea (mmol/L) 5.28 ± 2.3 5.42 ± 1.6 0.101
Serum creatinine (mmol/L) 91.70 ± 19.5 99.60 ± 23.5 0.022
Glomerular filtration rate (mL/min/1.72m2) 79.20 ± 19.2 75.40 ± 21.1 0.232a
Triglyceride (mmol/L) 2.35 ± 8.1 1.78 ± 1.0 0.276
Total cholesterol (mmol/L) 5.38 ± 5.9 4.50 ± 1.2 0.005
HDL cholesterol (mmol/L) 1.24 ± 0.4 1.98 ± 9.2 0.088
LDL cholesterol (mmol/L) 2.94 ± 0.9 2.53 ± 0.9 <0.0001
a
𝑃 values were obtained using independent 𝑡-test and other comparisons used Mann-Whitney 𝑈 test.
serum cholesterol, and low density lipoprotein in men with
diabetes and controls (Table 2).
3.1. RAS Variants and T2DM. Assessment of genotype dis-
tributions in both T2DM patients and controls indicated
no deviation from HWE, thus, providing confidence for the
genetic analysis. None of the investigated genetic variants
were associated with T2DM in the overall participants as
summarised in Supplementary Table 1 in Supplementary
Material available online at http://dx.doi.org/10.1155/2016/
2161376. Current opinion from the experts has suggested that
men are biologicallymore susceptible and develop diabetes at
even lower BMI than women [11]. Taking this into account,
we hypothesize that gender is a contributing factor and
may affect the study results. Surprisingly, analysis by gender
revealed that the genetic variants of AGT were significantly
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Table 3: Association of AGT SNPs with diabetes in the male gender.
AGT Allele frequency Unadjusted 𝑃 value Adjusted 𝑃 valuea ORa (95% CI)
Control DM
rs699 (T/C)
T 0.12 0.21 1 Reference
C 0.88 0.79 0.017 0.007 0.47 (0.27–0.81)
TT 1 Reference
TC 0.815 0.803 0.80 (0.14–4.66)
CC 0.395 0.209 0.33 (0.60–1.85)
rs4762 (C/T)
C 0.84 0.90 1 Reference
T 0.16 0.10 0.048 0.042 0.54 (0.29–0.98)
CC 1 Reference
CT 0.076 0.065 0.53 (0.27–1.04)
TT 0.245 0.320 0.31 (0.03–3.14)
rs5051 (A/G)
A 0.88 0.80 1 Reference
G 0.12 0.20 0.032 0.017 1.94 (1.13–3.36)
AA 1 Reference
AG 0.022 0.026 2.09 (1.09–4.00)
GG 0.414 0.226 2.87 (0.52–15.75)
aAdjusted for waist circumference, age, and BMI.
associated with T2DM only in male (Table 3). However,
none of the genetic variants within ACE and AGTR1 were
associated with T2DM (Supplementary Table 2).
The AGT rs699-C and rs4762-T alleles were significantly
higher in the controls compared to the patients (adjusted OR
0.47, 95% CI 0.27–0.81, 𝑃 = 0.007 and adjusted OR 0.54, 95%
CI 0.29–0.98, 𝑃 = 0.042, resp.), suggesting that these variants
are associated with reduced risk of T2DM. Nonetheless, the
AGT rs5051-G allele was associated with 1.94-fold increased
risk of T2DM (𝑃 = 0.017). These findings, after adjustments
for the confounding factors, clearly indicated that the variants
were independent predictors for T2DM. Although our initial
multivariate analysis found no contributing effect of age and
BMI, we ought to include these variables during the adjust-
ment as they are strong predictors for the development of
T2DM [12]. Differences observed between the patients and
controls, especially in fasting blood glucose and HbA1c, were
not adjusted for as these are diabetes-associated risk factors.
While dyslipidemia was excluded as it is attributed to
metabolic disorder from diabetes. Following correction for
multiple testing (0.05/6), only AGT rs699 𝑃 value remained
significant.
3.2. LinkageDisequilibriumandHaplotypeAssociation of AGT
Variants in the Male Gender. AGT variants appeared to be in
strong (𝐷󸀠 > 0.98) linkage disequilibrium (LD), suggesting
the tendency of the single nucleotide polymorphisms (SNPs)
to be coinherited. A small set of tag SNP would therefore be
sufficient to capture the genetic information of the gene. In
this study, three haplotypes inferred from rs699, rs4762, and
rs5051 (CCA, TCG, and CTA) were yielded with frequencies
above 5% (Table 4). Haplotype CCA (71%) was the most
Table 4: Association of haplotypes in AGT gene with diabetes in the
male gender.
Haplotype Control (%) Case (%) 𝑃 valuea ORb (95% CI)
CCA 0.721 0.691 0.457 0.859 (0.577–1.281)
TCG 0.117 0.202 0.012 1.917 (1.149–3.200)
CTA 0.157 0.103 0.078 0.615 (0.357–1.059)
a
𝑃 value was based on 100,000 permutations and bOR was calculated using
R program.
frequent followed by TCG (16%) and CTA (13%). Haplotype
analysis revealed that TCG was found to be associated with
T2DM (OR 1.92, 95% CI 1.15–3.20, permuted 𝑃 = 0.012). Tag
SNP was reported for AGT rs699.
3.3. RAS Gene-Gene Interactions. In order to understand the
genetic basis of T2DM, we evaluated the interactions at the
gene level. Analysis however indicated a lack of evidence for
gene-gene interactions within the RAS.
3.4. AGT rs699 Variant and Association with Clinical Param-
eters. We chose to explore the relationship between the AGT
rs699 and clinical parameters for the following reasons, (i)
the evidence of strong 𝑃 value in single marker analysis and
(ii) rs699 being a tagging SNP. There was no difference in
the levels of clinical parameters among the genotypes except
for FBG and HbA1c (𝑃 = 0.005 and 𝑃 = 0.012) (Supple-
mentary Table 3). These observations strongly imply that the
observed genetic association findings are likely to hold true
and intriguingly; the differences were also seen in men (𝑃 =
0.005 and 𝑃 = 0.01) but not in women. We then sought to
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investigate whether the variant was also correlated with the
levels of the parameters. We demonstrated marginal negative
correlations with FBG and HbA1c (𝑃 = 0.06 and 𝑃 = 0.052);
associations however improved when analysed in men (𝑃 =
0.04 and 𝑃 = 0.017). The results suggest that AGT variants
were independently associated with T2DM.
4. Discussion
Genome-wide association study (GWAS) is a comprehensive
and unbiased approach that is able to identify candidate
genemarkers encompassing the entire genome [13].However,
a major stumbling block to the successful execution of
the GWAS is the high cost for exhaustive genotyping due
to enormous number of SNPs in the entire genome. The
efficiency of GWAS often rests on a set of tag SNPs that serve
as proxies for the uncollected SNPs. Together with the fact
that frequency of allele is often population specific, there may
still be a need for candidate gene approach. In this study, we
examined the association of genetic variants of the RAS with
T2DM risk. Some of the variants are reported for the first
time in the present study. We also examined whether there
are gene-gene interactions within the RAS that can influence
patient’s susceptibility to T2DM. We showed that allele
frequencies of the AGT variants were significantly different
between the T2DM patients and controls, suggesting genetic
predisposition to T2DM.
Among the studied genes, only AGT was shown to be
associated with T2DM and this association was seen only in
men. Two AGT variants rs699 and rs4762 were associated
with reduced risk of T2DM while rs5051 was associated with
increased risk. Intriguingly, these three variants displayed
similar linkage disequilibrium structure and the haplotype
TCG was associated with increased risk of T2DM. Risk of
diabetic nephropathy was previously shown to be associated
with enrichment of this haplotype in the Tunisians [14]. Nev-
ertheless, exhaustive search of the literatures failed to find any
study that examined the haplotype association with T2DM,
making the present study the first to report this haplotype
association. AGT rs699-C allele was previously found to be
associated with increased risk of T2DM in the Pakistani [15],
despite no significant association in the Chinese [16] and
recently the Japanese [17]. The Pakistani and the Japanese
were not investigated by gender comparison whilst the Chi-
nese demonstrated neither association in men nor women.
Although these published studies and the present study
shared a common study population which is of Asian descen-
dent, the direction of findings was however different among
studies, indicating that population-specific candidate gene
study is still useful. Pakistan is one of the Asian countries
reported with high prevalence of diabetes compared to the
Malay, Chinese, and Japanese [18]. To date, there is only one
report on the association between AGT rs4762 and diabetes
[19]. The study examined the association of AGT rs4762
with diabetes in a post kidney transplant patients in Korea
and found that AGT rs4762 is associated with increased risk
of diabetes. Interestingly, the direction of finding from the
Korean also differs from us, suggesting ethnicity differences
may contribute to the conflicting results. It should also be
noted that the Korean study did not compare the gender. As
for AGT rs5051, to the best of our knowledge, there is no
published report on the association with diabetes, and our
study provides a novel report. We also failed to demonstrate
any significant association between variants within the ACE
and AGTR1 variants.
Genetic association studies between the RAS and T2DM
have not been extensively studied. Several RAS-related genes
interactions including ACE Ins/Del were reported in the
Chinese T2DM patients, but these associations were not seen
in single locus marker except forACE Ins/Del in women [16].
Nonetheless, interactions between the RAS genes were not
shown in our study. A meta-analysis conducted in different
Chinese ethnics revealed no significant association between
ACE Ins/Del and T2DM [20], which is supported by a
Japanese study [17]. Together, these observations indicate that
there are conflicting results in a small set of studies, thus
pointing for the need for further investigation into this rela-
tionship. In this study, AGT gene showed a modest but sig-
nificant influence toward the outcome of T2DM. The mech-
anisms of the AGT variants in causing T2DM are currently
unclear, but it is likely due to the impact of angiotensinogen
levels. Angiotensinogen is an adipokine component of the
RAS that is involved in the earlier part of the system cascade.
The angiotensinogenmRNA levels are highly expressed in the
visceral rather than the subcutaneous adipose tissue region
[21]. Despite presenting with no biological activity, once bro-
ken down to angiotensin II (AngII) via a consecutive action
of renin and ACE, it can induce insulin resistance via a cross-
talk mechanism between insulin and AngII signaling cascade
[6]. Transitional changes of amino acid methionine to thre-
onine (rs699) and threonine to methionine (rs4762) in the
exonic regions of AGT lead to alterations of the protein func-
tion thereby regulating theAGT expression and subsequently
plasma angiotensinogen levels [22]. Carriers of rs699-C allele
are reported with higher serum angiotensinogen levels [23].
On the other hand, the AGT promoter variant rs5051 has
been associated with an in vitro increase in AGT expression
[24].
In this study, two main diabetic traits (FBG and HbA1c)
reached significant associations with AGT genotypes. We
earlier indicate that these associations were independently
associated. This strongly suggests that a change in FBG and
HbA1c levels attributable to AGT genotypes has a metabolic
impact on the risk of T2DM. With reference to AGT rs699,
patients carrying the C-allele exhibit a trend of significant
reduction in FBG and HbA1c levels. Our results also showed
an association between haplotype TCG inferred from AGT
variants with risk of T2DM, with no line of evidence points
to significant gene-gene interactions. These findings support
the key role of angiotensinogen in insulin resistance and
genetic variants of AGT can serve as a predictive marker of
T2DM. To explore this further, it may be informative to assess
the angiotensinogen levels by genotype, which we did not
investigate in this study. Current knowledge has suggested
that AngII, the final product of RAS cascade, is working in
concert with oxidative stress to induce insulin resistance [25].
Future genetic association studies of RAS should therefore
examine both the AngII and oxidative stress levels in order
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to gain insight into this mechanism, although we note there
is some evidence for association of AGT genotypes with
reduced diabetic parameters.
The present study also identified two important factors
that contributed to the susceptibility to T2DM, particularly
male gender and waist circumference. Although we showed
that the variants of the AGT were independently associated
with T2DM, the influence of these factors in T2DM warrans
further discussion. Asian men are at greater risk for T2DM
compared to women [10]. Unlike the Caucasians who need to
be relatively big to get diabetes, the Asians develop diabetes
at even lower degree of obesity [26]. Similar trend is seen
when comparing with the Europeans, where both BMI and
waist circumference are lower in the South Asian men but
the visceral adiposity is larger [27].The notion that one’s BMI
measures one’s waist and thus indicating diabetes, however,
cannot be extrapolated at the Asian level. India for example,
despite having low prevalence of obesity, they have notably
high rates of T2DM [28]. Our data indicate that genetic vari-
ants of AGT in men make them more predisposed to T2DM
and out of the 290 patients with T2DM, only 24%were obese.
There is a likelihood of 53% risk reduction of T2DM in men
subjected to variation in AGT rs699 and 47% risk reduction
when confounded by waist circumference. In other word, the
risk of diabetes is relatively high in Asian men with greater
waist circumference, and the risk is higher when presented
with susceptible genetic variations. The findings suggest
that male gender and waist circumference are among the
important factors need to be considered when analysing data
involving Asian population, and this is one of the strengths in
this study.
Results from studies of complex diseases like diabetes are
not easily reproducible in different set of population com-
monly due to polygenic inheritance and gene-environment
interactions [29]. In this study, we have eliminated the gene-
gene interaction and confounding effects. Thus, our results
fall within the assumption that the genetic variants of theAGT
were independently associated with T2DM.Nevertheless, the
gene-environment interactions such as physical activity and
diet were not investigated and thus could be a limitation of
this study. This limitation has been shared by many other
genetic association studies including GWAS. More impor-
tantly, the GWAS has a limited success to identify new gene
variants (especially those with low allele frequency) associ-
ated with disease susceptibility owing to the complexity of the
disease and the key element of exposure and further substan-
tiated by the number of independent tests performed [30].
Another limitation is associated with relatively small sample
size of the patients.The said high prevalence of T2DMamong
the Asians should reflect a greater number of T2DM patients
in our study; however, this was not achieved. This limitation
is conditioned by several factors: (i) we recruited only Malay
T2DMparticipants; (ii) the catchment area ismore populated
by the Chinese; and (iii) this study includes only a cohort
from one centre. Measurement of plasma angiotensinogen
levels would have been useful in view of the proposed
importance of AngII, a breakdown product of angiotensino-
gen, in accentuating the T2DM risk in men, but these
measurements have not been made. However, studies have
demonstrated that angiotensinogen levels are strongly cor-
related with AGT variants [22]. Hence, further replication
studies are required to confirm these findings.
5. Conclusion
Taken together, the present study provides a support on the
association of genetic variants of the AGT gene with risk
of T2DM. These RAS variants could serve as independent
genetic predictors for the T2DM in the area of personal-
ized medicine involving metabolic diseases. Further studies
that include more variants of the RAS and examine the
angiotensinogen and oxidative stress levels are necessary
to dissect the potential role of these genetic variants as a
predictive genetic marker for T2DM.
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